AHRQ Patient Safety Network ► Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome.

AHRQ Patient Safety Network





Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome.

Mehta RH, Chen AY, Alexander KP, Ohman EM, Roe MT, Peterson ED. Circulation. 2015;131:980-987.

Guidelines for the care of patients with acute coronary syndromes recommend aggressive therapy with certain medications, such as antiplatelet therapies that carry a risk of bleeding complications. This cohort study found only a weak relationship between quality (measured as adherence to guideline-recommended therapy) and safety (measured as major bleeding rates) at the individual hospital level. Hospitals that maximized both quality and safety had the best patient outcomes.

PubMed citation 
Available at 
Free full text 

Related Resources

STUDY

Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes.

Alexander KP, Chen AY, Roe MT, et al; CRUSADE Investigators. JAMA. 2005;294:3108-3116.

STUDY

Factors associated with reported preventable adverse drug events: a retrospective, case-control study.

Beckett RD, Sheehan AH, Reddan JG. Ann Pharmacother. 2012;46:634-641.

COMMENTARY

Are Two Insulin Pumps Better Than One?

Cook CB. AHRQ WebM&M [serial online]. January 2009.

STUDY

Medication safety program reduces adverse drug events in a community hospital.

Cohen MM, Kimmel NL, Benage MK, et al. Qual Saf Health Care. 2005;14:169-174.

View all related resources...